McFarlane Neil F.
President and CEO
Sale 10b5-1
- Shares
- 20,000
- Price
- $11.25
- Value
- $224,948
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•30 filings
ZVRA
ZEVRA THERAPEUTICS, INC.
Net sales of $838.1K over the last 3 months
3 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$838,100
0 buyers · 3 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$2,520,623
6 distinct insiders
Highlighted alerts
4
13 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get ZVRA insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
ZVRA overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
68
Raw transactions
Everything returned by the filing
17
Voluntary view
P/S trades after deterministic checks
51
Administrative noise
Stored, never alerted
43
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- M
- Shares
- 50,000
- Price
- —
- Footnotes
- 4
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. Adoption date of referenced 10b5-1(c) plan is: 03-25-2026 This transaction was executed in multiple trades at prices ranging from $11.07 to $11.36. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. 25% of the RSUs vested and settled on each of October 10, 2024, October 10, 2025 and October 10, 2026. The remaining 25% of the shares will vest on 10/10/2027, provided that at the relevant vesting date the Reporting Person's employment relationship has not been terminated as defined in the Issuer's 2023 Employment Inducement Award Plan. All shares will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason.
Raspberry interpretation
Informational — no alert
Reason: administrative_code. The trade is reported under a Rule 10b5-1 plan.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Thompson Rahsaan
Chief Legal & Compliance
Sale 10b5-1
- Shares
- 42,666
- Price
- $11.13
- Value
- $474,774
Watton Corey Michael
Director
SaleAlert
- Shares
- 12,300
- Price
- $11.25
- Value
- $138,377
Thompson Rahsaan
Chief Legal & Compliance
Sale 10b5-1
- Shares
- 34,557
- Price
- $12.68
- Value
- $438,304
Thompson Rahsaan
Chief Legal & Compliance
Sale 10b5-1
- Shares
- 1,794
- Price
- $11.30
- Value
- $20,272
McFarlane Neil F.
President and CEO
Sale 10b5-1
- Shares
- 14,625
- Price
- $8.56
- Value
- $125,186
Schafer Joshua
CCO
Sale 10b5-1
- Shares
- 10,500
- Price
- $9.19
- Value
- $96,500
Sangiovanni Timothy J.
SVP, Finance & Corp Controller
Sale 10b5-1
- Shares
- 3,000
- Price
- $9.18
- Value
- $27,548
McFarlane Neil F.
President and CEO
Sale 10b5-1
- Shares
- 91,000
- Price
- $9.38
- Value
- $853,425
Schafer Joshua
CCO
Sale 10b5-1
- Shares
- 3,375
- Price
- $8.83
- Value
- $29,800
Quartel Adrian W
Chief Medical Officer
Sale 10b5-1
- Shares
- 4,533
- Price
- $8.83
- Value
- $40,036
Thompson Rahsaan
Chief Legal & Compliance
Sale 10b5-1
- Shares
- 4,080
- Price
- $8.83
- Value
- $36,010
Sangiovanni Timothy J.
SVP, Finance & Corp Controller
Sale 10b5-1
- Shares
- 1,750
- Price
- $8.82
- Value
- $15,442
McFarlane Neil F.
President and CEO
Sale 10b5-1
- Shares
- 19,500
- Price
- $10.82
- Value
- $210,908
Shih Alvin
Director
PurchaseAlert
- Shares
- 20,000
- Price
- $7.89
- Value
- $157,800
FAVORITO TAMARA A
Director
PurchaseAlert
- Shares
- 3,175
- Price
- $7.79
- Value
- $24,718
Bode John B
Director
PurchaseAlert
- Shares
- 5,000
- Price
- $9.17
- Value
- $45,825
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Oct 12, 2026 | McFarlane Neil F. President and CEO | Sale | 20,000 | $11.25 | $224,948 | |
| Aug 14, 2026 | Thompson Rahsaan Chief Legal & Compliance | Sale | 42,666 | $11.13 | $474,774 | |
| Aug 10, 2026 | Watton Corey Michael Director | Sale | 12,300 | $11.25 | $138,377 | |
| Jun 22, 2026 | Thompson Rahsaan Chief Legal & Compliance | Sale | 34,557 | $12.68 | $438,304 | |
| May 11, 2026 | Thompson Rahsaan Chief Legal & Compliance | Sale | 1,794 | $11.30 | $20,272 | |
| Feb 09, 2026 | McFarlane Neil F. President and CEO | Sale | 14,625 | $8.56 | $125,186 | |
| Feb 03, 2026 | Schafer Joshua CCO | Sale | 10,500 | $9.19 | $96,500 | |
| Feb 03, 2026 | Sangiovanni Timothy J. SVP, Finance & Corp Controller | Sale | 3,000 | $9.18 | $27,548 | |
| Feb 02, 2026 | McFarlane Neil F. President and CEO | Sale | 91,000 | $9.38 | $853,425 | |
| Jan 30, 2026 | Schafer Joshua CCO | Sale | 3,375 | $8.83 | $29,800 | |
| Jan 30, 2026 | Quartel Adrian W Chief Medical Officer | Sale | 4,533 | $8.83 | $40,036 | |
| Jan 30, 2026 | Thompson Rahsaan Chief Legal & Compliance | Sale | 4,080 | $8.83 | $36,010 | |
| Jan 30, 2026 | Sangiovanni Timothy J. SVP, Finance & Corp Controller | Sale | 1,750 | $8.82 | $15,442 | |
| Oct 10, 2025 | McFarlane Neil F. President and CEO | Sale | 19,500 | $10.82 | $210,908 | |
| Sep 12, 2025 | Shih Alvin Director | Purchase | 20,000 | $7.89 | $157,800 | |
| Sep 12, 2025 | FAVORITO TAMARA A Director | Purchase | 3,175 | $7.79 | $24,718 | |
| Aug 19, 2025 | Bode John B Director | Purchase | 5,000 | $9.17 | $45,825 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.